Emerging studies have consistently demonstrated that genetic polymorphisms in H19 gene are associated with the risk or prognosis of various cancers, including gastric cancer (21), colorectal cancer (22), bladder cancer (23, 24) and breast cancer (25). Here, H19 is linked to breast carcinoma.